On Air with Immunocine: Matt Halpert Joins Haylie Pomroy to Discuss the Future of Cancer Treatment
In this episode of the Hope and Help for Fatigue and Chronic Illness Podcast, Haylie Pomroy interviews Matt Halpert, Ph.D to explore the future of cancer treatment. They discuss how immunotherapy trains the immune system to recognize and combat cancer more effectively, and how Immunocine can offer a more targeted approach with fewer side effects than traditional treatments.
“First of all, it’s making a tremendous impact, but furthermore it’s going to change the trajectory of cancer care.” – Haylie Pomroy
Matt Halpert, Ph.D explains the critical role dendritic cells play in the immune system and how Immunocine is using this knowledge to develop personalized cancer therapies. This discussion provides valuable insights for those holding hope new treatment options that could change their lives.
READ THIS NEXT
The Checkpoint Inhibitor Revolution: Why the First Trials Changed Everything
In March 2011, the FDA approved a drug that would fundamentally change our understanding of cancer treatment forever. Ipilimumab (Yervoy), t
Read More
On Air with Immunocine: Matt Halpert Joins Heal Navigator to Discuss How the IDCT is Changing Lives Today
https://www.youtube.com/watch?v=SnFprB1I_K8&list=PLCaoz22dM92-Co9qqZESVpw-GNUdB0MV9 Listen to this Episode on Apple Podcasts Listen to
Read More
Team Spotlight: Susana Hernandez, MSc
Meet Susana Hernandez, Immunocine’s Director of Cell Therapy. Based in Cancun, Susana blends deep scientific expertise with a lifelong pas
Read More
